Destination XL Group could reject Fund 1 Investments' takeover bid of $3 per share, causing the shares to drop. Read here why ...

Patrick Trucchio, an analyst from H.C. Wainwright, reiterated the Buy rating on ATAI Life Sciences (ATAI – Research Report). The associated ...

The late guitarist shared insights into his influences and techniques in an interviewer for our May 1999 issue ...

AstraZeneca is a leader in cancer treatments with FDA-approved drugs. Read why AZN stock is still a 'Buy' and why the company’s future looks bright.

Feeling clueless ahead of the big day? BH's curated guide to Valentine's Day gifts for her in 2025 has got you covered. Check ...

Next up is the artist with the most Grammy nominations in R&B at this year's upcoming ceremony and she's already scored 4 #1 ...

Amid reports he’ll be performing at Donald Trump’s inauguration, here’s a look at rapper Snoop Dogg’s net worth.

It's going to be a rather dull MLK weekend at the box office, that is unless Sony's R-rated femme comedy 'One of Them Days' ...

What will be the winners and the losers this week at the U.S. box office? Universal and Blumhouse’s horror flick Wolf Man, ...